Cargando…
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
The ability of interleukin (IL)-12 to prevent tumors when administered to individuals with a genetic risk of cancer was studied in two lines of transgenic mice expressing rat HER-2/neu oncogene in the mammary gland. Female BALB/c (H-2(d)) mice carrying the activated HER-2/ neu oncogene show no morph...
Autores principales: | Boggio, Katia, Nicoletti, Giordano, Di Carlo, Emma, Cavallo, Federica, Landuzzi, Lorena, Melani, Cecilia, Giovarelli, Mirella, Rossi, Ilaria, Nanni, Patrizia, De Giovanni, Carla, Bouchard, Page, Wolf, Stanley, Modesti, Andrea, Musiani, Piero, Lollini, Pier Luigi, Colombo, Mario P., Forni, Guido |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212479/ https://www.ncbi.nlm.nih.gov/pubmed/9687535 |
Ejemplares similares
-
Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
por: Nanni, Patrizia, et al.
Publicado: (2001) -
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Nanni, Patrizia, et al.
Publicado: (2018) -
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015) -
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
por: De Giovanni, Carla, et al.
Publicado: (2019) -
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
por: Nanni, P., et al.
Publicado: (1996)